Patents by Inventor James A. Hoffmann

James A. Hoffmann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10188408
    Abstract: This preparation set comprises a drill guide (31) comprising a bearing surface (33) intended to bear against a glenoid cavity, a passage orifice (35) intended for the passage of a guide pin (36) implanted in the glenoid cavity, and first and second guide orifices (37, 38) each opening into the bearing surface (33) and each intended to guide a drill bit (38) capable of realizing a bone bore in the glenoid cavity, the first and second guide orifices (37, 38) being inclined with respect to the extension axis of the passage orifice (35) and converging in the direction of the bearing surface (33); and a compactor (42) comprising a compaction portion (45) having a generally trapezoidal shape and intended to be impacted against the glenoid cavity so as to form a bone housing in the glenoid cavity, the compactor (42) further including a passage hole (49) extending at least partially in the compaction portion (45) and intended for the passage of the guide pin (36) implanted in the glenoid cavity.
    Type: Grant
    Filed: October 18, 2016
    Date of Patent: January 29, 2019
    Assignees: FOURNITURES HOSPITALIERES INDUSTRIE, FH ORTHOPEDICS, DURHAM VALLEY ORTHOPEDIC CONSULTANTS LLC
    Inventors: Guillaume Rouyer, James Hoffmann, Bruce Miller
  • Publication number: 20180103967
    Abstract: This preparation set comprises a drill guide (31) comprising a bearing surface (33) intended to bear against a glenoid cavity, a passage orifice (35) intended for the passage of a guide pin (36) implanted in the glenoid cavity, and first and second guide orifices (37, 38) each opening into the bearing surface (33) and each intended to guide a drill bit (38) capable of realizing a bone bore in the glenoid cavity, the first and second guide orifices (37, 38) being inclined with respect to the extension axis of the passage orifice (35) and converging in the direction of the bearing surface (33); and a compactor (42) comprising a compaction portion (45) having a generally trapezoidal shape and intended to be impacted against the glenoid cavity so as to form a bone housing in the glenoid cavity, the compactor (42) further including a passage hole (49) extending at least partially in the compaction portion (45) and intended for the passage of the guide pin (36) implanted in the glenoid cavity.
    Type: Application
    Filed: October 18, 2016
    Publication date: April 19, 2018
    Inventors: Guillaume ROUYER, James HOFFMANN, Bruce MILLER
  • Publication number: 20100125533
    Abstract: A computer system is operated to allow an existing investor to keep an investment in an alternative investment fund, even though the existing investor lacks the funds to pay for the unfunded capital commitments by transferring a percentage of the obligation to fund future commitment to a prospective investor. An agreement maintains privity of contract between the existing investor and the investment vehicle (a Separate Account) comprised of a fund investment manager and an investor and is managed by a fund manager for the prospective investor. The computer system operates to execute the terms of the contract such that the existing investor receives distributions from investments in the underlying alternative investment fund after payment of amounts due to the Separate Account in preference to the existing investor.
    Type: Application
    Filed: September 15, 2009
    Publication date: May 20, 2010
    Inventors: Michael James Hoffmann, Craig Adam Marmer
  • Patent number: 7232879
    Abstract: The present invention provides novel complexes consisting of certain GLP-1 molecules associated with a divalent metal cation that is capable of co-precipitating with a GLP-1 molecule. Pharmaceutical compositions and methods of using such complexes for enhancing the expression of insulin in B-type islet cells is claimed, as is a method for treating maturity onset diabetes mellitus in mammals, particularly humans.
    Type: Grant
    Filed: January 30, 2004
    Date of Patent: June 19, 2007
    Assignee: Eli Lilly and Company
    Inventors: John A. Galloway, James A. Hoffmann
  • Publication number: 20060241047
    Abstract: This invention relates to FSH or a FSH variant containing an alpha and beta subunit contained in formulations, and articles of manufacture. The invention provides advantageous new proteins and nucleic acids, multi-use pharmaceutical solutions, formulations and products of said proteins and nucleic acids where none approved for commercial use had previously existed having such extended use indications. These products are particularly useful in therapeutic regimens for increasing serum levels of FSH or a FSH variant over a period of treatment. Thus, inter alia, the invention fills the need for convenient products of FSH or from a FSH variant.
    Type: Application
    Filed: July 7, 2006
    Publication date: October 26, 2006
    Inventors: James Hoffmann, Jirong Lu
  • Publication number: 20060073757
    Abstract: A process for anodically bonding an array of spacer columns to one of the inner major faces on one of the generally planar plates of an evacuated, flat panel video display. The process includes using a generally planar plate having a plurality of spacer column attachment sites; providing electrical interconnection between all attachment sites; coating each attachment site with a patch of oxidizable material; providing an array of unattached permanent glass spacer columns, each unattached permanent spacer column being of uniform length and being positioned longitudinally perpendicular to a single plane, with the plane intersecting the midpoint of each unattached spacer column; positioning the array such that an end of one permanent spacer column is in contact with the oxidizable material patch at each attachment site; and anodically bonding the contacting end of each permanent spacer column to the oxidizable material layer.
    Type: Application
    Filed: November 21, 2005
    Publication date: April 6, 2006
    Inventors: James Hoffmann, Jason Elledge
  • Publication number: 20060023860
    Abstract: A method of detecting misrouted inter-office transport facility routes in a telecommunications system is disclosed. The method includes receiving a plurality of provisioning orders corresponding to a plurality of newly requested inter-office facility routes to be added to the telecommunications system, and comparing the plurality of newly requested inter-office facility routes to a plurality of preferred routes that have been stored in a preferred routes database to identify a first set of routes that match the preferred routes, a second set of misrouted routes where a preferred route has been defined and previously stored, but where the newly requested route does not match the preferred route, and a third set of unmatched routes where a preferred route has not been previously stored in the preferred routes database.
    Type: Application
    Filed: July 29, 2004
    Publication date: February 2, 2006
    Inventors: Frederick Armanino, Tomoko Convis, Raghvendra Savoor, James Hoffmann, Jerold Osato, David Berendsen, Richard Hawthorne, Randal Biederstedt, David Curry
  • Publication number: 20040127399
    Abstract: The present invention provides novel complexes consisting of certain GLP-1 molecules associated with a divalent metal cation that is capable of co-precipitating with a GLP-1 molecule. Pharmaceutical compositions and methods of using such complexes for enhancing the expression of insulin in B-type islet cells is claimed, as is a method for treating maturity onset diabetes mellitus in mammals, particularly humans.
    Type: Application
    Filed: January 30, 2004
    Publication date: July 1, 2004
    Inventors: John A. Galloway, James A. Hoffmann
  • Patent number: 6703365
    Abstract: The present invention provides novel complexes consisting of certain GLP-1 molecules associated with a divalent metal cation that is capable of co-precipitating with a GLP-1 molecule. Pharmaceutical compositions and methods of using such complexes for enhancing the expression of insulin in B-type islet cells is claimed, as is a method for treating maturity onset diabetes mellitus in mammals, particularly humans.
    Type: Grant
    Filed: April 17, 2002
    Date of Patent: March 9, 2004
    Assignee: Eli Lilly and Company
    Inventors: John A. Galloway, James A. Hoffmann
  • Publication number: 20020165342
    Abstract: The present invention provides novel complexes consisting of certain GLP-1 molecules associated with a divalent metal cation that is capable of co-precipitating with a GLP-1 molecule. Pharmaceutical compositions and methods of using such complexes for enhancing the expression of insulin in B-type islet cells is claimed, as is a method for treating maturity onset diabetes mellitus in mammals, particularly humans.
    Type: Application
    Filed: April 17, 2002
    Publication date: November 7, 2002
    Inventors: John A. Galloway, James A. Hoffmann
  • Patent number: 6388053
    Abstract: The present invention provides novel complexes consisting of certain GLP-1 molecules associated with a divalent metal cation that is capable of co-precipitating with a GLP-1 molecule. Pharmaceutical compositions and methods of using such complexes for enhancing the expression of insulin in B-type islet cells is claimed, as is a method for treating maturity onset diabetes mellitus in mammals, particularly humans.
    Type: Grant
    Filed: October 12, 2001
    Date of Patent: May 14, 2002
    Assignee: Eli Lilly and Company
    Inventors: John A. Galloway, James A. Hoffmann
  • Patent number: 6133235
    Abstract: The present invention provides novel complexes consisting of certain GLP-1 molecules associated with a divalent metal cation that is capable of co-precipitating with a GLP-1 molecule. Pharmaceutical compositions and methods of using such complexes for enhancing the expression of insulin in B-type islet cells is claimed, as is a method for treating maturity onset diabetes mellitus in mammals, particularly humans.
    Type: Grant
    Filed: July 6, 1999
    Date of Patent: October 17, 2000
    Assignee: Eli Lilly and Company
    Inventors: John A. Galloway, James A. Hoffmann
  • Patent number: 6024349
    Abstract: A stabilizing fixture particularly suited for use with a robot end effector and holding relatively flexible components while they are cut, trimmed, or otherwise machined by the end effector. The fixture includes a chassis with wheels and a plurality of upwardly projecting posts that support an upper frame. The upper frame defines a platform for supporting, aligning, and stabilizing a flexible workpiece. The frame includes a two L-shaped brackets to support the workpiece and one or more vacuum-powered suction cups for tightly gripping and holding the workpiece against the brackets.
    Type: Grant
    Filed: May 12, 1998
    Date of Patent: February 15, 2000
    Assignee: ABB Flexible Automation, Inc.
    Inventors: James A. Hoffmann, Douglas L. St. Onge
  • Patent number: 5977071
    Abstract: The present invention provides novel complexes consisting of certain GLP-1 molecules associated with a divalent metal cation that is capable of co-precipitating with a GLP-1 molecule. Pharmaceutical compositions and methods of using such complexes for enhancing the expression of insulin in B-type islet cells is claimed, as is a method for treating maturity onset diabetes mellitus in mammals, particularly humans.
    Type: Grant
    Filed: September 10, 1997
    Date of Patent: November 2, 1999
    Assignee: Eli Lilly and Company
    Inventors: John A. Galloway, James A. Hoffmann
  • Patent number: 5851995
    Abstract: The present invention provides anti-obesity proteins, which when administered to a patient regulate fat tissue. Accordingly, such agents allow patients to overcome their obesity handicap and live normal lives with much reduced risk for type II diabetes, cardiovascular disease and cancer.
    Type: Grant
    Filed: August 4, 1997
    Date of Patent: December 22, 1998
    Assignee: Eli Lilly and Company
    Inventors: Margret B. Basinski, Richard D. DiMarchi, David B. Flora, William F. Heath, Jr., James A. Hoffmann, Brigitte E. Schoner, James E. Shields, David L. Smiley
  • Patent number: 5765975
    Abstract: A compliant end effector particularly suited for use with a robotic arm for accurately cutting and trimming the edges of a hot molded sheet of flexible plastic. The compliant end effector includes a mount secured to the robotic arm, an adjustment assembly pivotally attached to the mount, a guide that engages the plastic sheet near the area to be cut and trimmed, a tool for cutting and trimming the flexible sheet, and a pneumatic cylinder that biases the guide into engagement with the flexible sheet and presses the sheet against a rigid surface. The pneumatic cylinder moves the guide and tool through a range of positions as the robotic arm moves along a single path of travel down the length of the flexible sheet. The guide remains in contact with the flexible sheet despite warping or other imperfections in the stabilizing surface. The tool is fixed a predetermined distance from the guide to ensure that the plastic sheet is cut and trimmed within specific tolerances.
    Type: Grant
    Filed: September 5, 1996
    Date of Patent: June 16, 1998
    Assignee: ABB Flexible Automation, Inc.
    Inventors: James A. Hoffmann, Douglas L. St. Onge
  • Patent number: 5719266
    Abstract: The present invention provides anti-obesity proteins, which when administered to a patient regulate fat tissue. Accordingly, such agents allow patients to overcome their obesity handicap and live normal lives with much reduced risk for type II diabetes, cardiovascular disease and cancer.
    Type: Grant
    Filed: March 17, 1995
    Date of Patent: February 17, 1998
    Assignee: Eli Lilly and Company
    Inventors: Richard D. DiMarchi, Ronald N. Hermeling, James A. Hoffmann
  • Patent number: 5705483
    Abstract: The present invention provides novel complexes consisting of certain GLP-1 molecules associated with a divalent metal cation that is capable of co-precipitating with a GLP-1 molecule. Pharmaceutical compositions and methods of using such complexes for enhancing the expression of insulin in B-type islet cells is claimed, as is a method for treating maturity onset diabetes mellitus in mammals, particularly humans.
    Type: Grant
    Filed: March 21, 1995
    Date of Patent: January 6, 1998
    Assignee: Eli Lilly and Company
    Inventors: John A. Galloway, James A. Hoffmann
  • Patent number: 5698669
    Abstract: This invention relates to human insulin analogs (tri-arg insulins) and includes two enzymatic methods for producing tri-arg insulins. These compounds can be formulated as a soluble entity up to pH 6.1 and have prolonged hypoglycemic activity. Tri-arg insulins have the basic structure of natural human insulin plus three additional arginine residues. Two of the three additional Arg residues are located in tandem at the carboxy terminus of the insulin B-chain, and the third Arg residue is located at the amino terminus of the insulin A-chain. Tri-arg insulin analogs, having certain amino acid substitutions at the B3, B10 and A21 positions, are within the instant invention.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: December 16, 1997
    Assignee: Eli Lilly and Company
    Inventors: James A. Hoffmann, Peter K. Lambooy
  • Patent number: 5691309
    Abstract: The present invention provides anti-obesity proteins, which when administered to a patient regulate fat tissue. Accordingly, such agents allow patients to overcome their obesity handicap and live normal lives with much reduced risk for type II diabetes, cardiovascular disease and cancer.
    Type: Grant
    Filed: February 6, 1995
    Date of Patent: November 25, 1997
    Assignee: Eli Lilly and Company
    Inventors: Margret B. Basinski, Richard D. DiMarchi, David B. Flora, William F. Heath, Jr., James A. Hoffmann, Brigitte E. Schoner, James E. Shields, David L. Smiley